[Hazard identification of nanomaterials]

Area of Science:

• Nanomaterial safety assessment
• Toxicology and hazard identification
• Biomonitoring of engineered nanoparticles

Context:

• Emerging manufactured nanomaterials pose potential novel biological or adverse health effects.
• Public exposure to many nanomaterials has not yet begun, offering a window for proactive safety measures.
• Integrating hazard information into product development is essential for safer nanotechnology.

Purpose:

• To develop experimental protocols for evaluating the health risks of manufactured nanomaterials.
• To establish detection and measurement methods for nanomaterials within biological systems.
• To support the creation of safer nanomaterial-based products through early hazard identification.

Summary:

• Research projects funded by the Ministry of Health, Labour and Welfare focus on developing methods for monitoring health risks associated with manufactured nanomaterials.
• Key areas include the development of in vitro and in vivo experimental systems, with a focus on long-term health implications like carcinogenesis, and appropriate inhalation systems.
• Initial testing involves high-production volume materials such as fullerene (C60), titanium dioxide, and multi-walled carbon nanotubes.

Impact:

• Enables the development of safer nanomaterial products by feeding hazard data back into the design phase.
• Provides a framework for proactive risk management in the nanotechnology industry.
• Facilitates informed decision-making for manufacturers regarding the safety of new materials before widespread market introduction.